{"name":"Agilent Technologies","slug":"agilent","ticker":"A","exchange":"NYSE","domain":"agilent.com","description":"Agilent Technologies, Inc. is an American global company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories. Agilent was established in 1999 as a spin-off from Hewlett-Packard. The resulting initial public offering of Agilent stock was the largest in the history of Silicon Valley at the time. From 1999 to 2014, the company produced optics, semiconductors, EDA software and test and measurement equipment for electronics; that division was spun off to form Keysight. Since then, the company has continued to expand into pharmaceutical, diagnostics & clinical, and academia & government (research) markets.","hq":"Santa Clara, CA, USA","founded":0,"employees":"18000","ceo":"Padraig McDonnell","sector":"Analytical Instruments / Diagnostics / Genomics","stockPrice":116.61,"stockChange":2.73,"stockChangePercent":2.4,"marketCap":"$33.0B","metrics":{"revenue":6500000000,"revenueGrowth":7,"grossMargin":52.3,"rdSpend":455000000,"netIncome":1303000000,"cash":1758000000,"dividendYield":0.89,"peRatio":25.7,"fiscalYear":"FY2017"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"IgM Enzyme-Linked Immunosorbent Assay (ELISA) patent cliff ($100M at risk)","drug":"IgM Enzyme-Linked Immunosorbent Assay (ELISA)","type":"patent_expiry","sentiment":"negative"},{"date":"2028-06-01","label":"Agilent's Mass Spectrometry Systems patent cliff ($500M at risk)","drug":"Agilent's Mass Spectrometry Systems","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2023-02-22","type":"earnings","headline":"Agilent Technologies Reports Fourth-Quarter and Full-Year 2022 Results","summary":"Agilent reported fourth-quarter and full-year 2022 results, with revenue of $1.73 billion and $6.85 billion, respectively.","drugName":"","sentiment":"neutral"},{"date":"2022-10-25","type":"deal","headline":"Agilent Technologies to Acquire Resolution Bioscience","summary":"Agilent announced the acquisition of Resolution Bioscience, a provider of next-generation sequencing (NGS) solutions.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2026-04-03","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOSWpuWUM5bjVMT3BRTGUyY3RhWFdYdWZ4U3VNcFQ1QzFlQno1WWs4QWxwbmhSQzg5eDUwTlF4ZU1PLVBDRlRBSUZhT3JpMnplR0k2a3VGSlBSNmlPd2JZQWxJY0hlX3JOZmZYSXF6Ui1yYUZicFUxTE9LM1d1TDVGNENPbXUwYV9JRHR2SjdheEJhVjI1TVFtTjI5VHU3XzRFYzFxcVc1VdIBrgFBVV95cUxNTkkyeXVteEdrV21oN1kxUU40anJhZHdBa2xrS0RhTzZuZFEzdlZaLUJYTFVPeVNIMURrWUlMYmV1WXUtUXFIUjBFNGdiNUZlT05aZmtZZjVvV2F0MDFFTVRpVno3MTRnTy1rSE43dXdaTTdYMDcxbG4tLWV0ZTR6RU5QQWlmZkJ0Y29McHNjN0tmTVFCZkdqSFZ1UTVFRFpkTGdZUzlyQzh4MFZmQmc?oc=5","date":"2026-04-02","type":"pipeline","source":"Indian Pharma Post","summary":"Agilent opens new customer experience center in Mumbai - Indian Pharma Post","headline":"Agilent opens new customer experience center in Mumbai","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWXlvT2p4OGdEY19vdXN6ZW9wVkowckE2TE04Rk1ycVJpNUVZRnJ5SlFlbnR0YkRrUlpyTTNqc1RaODNUNjVfTGdRRGF0Q1Fhbmlzc0ZLX3kwcDdlUnNfSmZnTFJrRGJpLWgxUWQ3RDNzY1Q5OU9KdS1ZY0hBRWgxR2gtcl9aZ3o1NEVSd2hHcWRCREJQTVJmZExVbkRvU0xyS1lmQtIBqgFBVV95cUxQUy1hemlyRndOdUI4Tm40Z2wyVTdtQ2pRVTRRcE1pckR1VjBKU2tJcGZ4dng3ZGQ4X3ZjYzhQRDBSUWFTeHo5QjJhUUVKWWhkanFsaDNhWk44c2hZQ0Z3T1p4QTRaYmkwWXlkZkxKeWFLVGR2ZWZkODVaSnBFWHZzcXhlMXdJZ0JuZUJpVDR4NnVnbEU5MHUwZkRabndhT2dTRlUzSE9BYUI3dw?oc=5","date":"2026-04-02","type":"pipeline","source":"Express Pharma","summary":"Mumbai Experience Center reflects Agilent’s continued commitment to India - Express Pharma","headline":"Mumbai Experience Center reflects Agilent’s continued commitment to India","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZTJVaV9JdldDYXhFLWZCSTVVY0ZZeFl5WGttOGVXbTRMSVg0bE4zZ2tLem5SY2V2TEIza0wtNnpIYVlrN1ZKX084SW4wY3FlZTBCd2luMXl2OXd3bXJEN3VrSjFCa0VvQlo4aFRkRzBPaVkxREZldDl6WTh4bm1sTUVjcnZLZTBaajV6N0g0VU0yV0J6eWpObGdnYlB1NGZucnRvQzVVRUtDMGhhRTRSdkp4bFNPaGoxQWVQdWVrVTlIREk?oc=5","date":"2026-03-23","type":"pipeline","source":"AD HOC NEWS","summary":"Agilent Technologies Advances Chromatography Innovations for Pharma and Biotech Efficiency in 2026 - AD HOC NEWS","headline":"Agilent Technologies Advances Chromatography Innovations for Pharma and Biotech Efficiency in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOMWxlTW9QZzlEOXpZcjBZbnNVSnVPNTFZOE1leVM5OGEzQnRBVUFqOEYzUTNWeWdmWjdRYlo3VzNIbWx1UWxQM2F3bFV1bXFURzZRSTVyNS16TUFzMGUyTl9hX0owUTFHRHo1ZjgwOWllWWFQdDF0eVA0d0hEaEJ3SHgweldoVGd0TmlFWnY0UnpMXzdVNXAtUzNFNlN2eFFJNFRERmdtelFYMGtRZ2lBTWpRNHpwX01RNngyTU5uTkVMTjg?oc=5","date":"2026-03-22","type":"pipeline","source":"AD HOC NEWS","summary":"Agilent Technologies Advances Chromatography Innovations for Pharma and Biotech in 2026 - AD HOC NEWS","headline":"Agilent Technologies Advances Chromatography Innovations for Pharma and Biotech in 2026","sentiment":"neutral"},{"date":"2026-03-20","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQbHJDWTlEZXBXUGhYOUNXbl9xREtSMkZhcVgtN0Nza1h5MkUxNUdLUHc1Z1MwdGx4ZU91ekFQeTM1XzZXQTR4YV90MDl4eE1uRjVQejNRV1p6d21tTmZZblZoN2k2Y2RvdmlJTWNaalpEcWd0YzNob2ZZNkFmV192dzY1YnczdDMyMlFDYlF4VkU2b1RsUG5lUnZB?oc=5","date":"2026-03-19","type":"pipeline","source":"Contract Pharma","summary":"Agilent Launches Agilent Advanced Therapeutics - Contract Pharma","headline":"Agilent Launches Agilent Advanced Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxORGVVc2daUHZEZml5ZFhLM2RraGxLa2ljVWxNc0QtakdOazctN2VOLWZlVXJiNXFSUHctQWdwbUFoTFJwS0tEeUNmTFlwZGpYTldmUW5yS29FYk1IWXZlSk1NVmpJWlVPR1laYS15bzMzNGU2VC04anNFa09BeE5HaUlaNkZseVhqRnpBdTFUM2Y4ZHlOM01kcnp4SnpXU3lFSU55ZjN3MVlZQncya25INGY2ZGV4UDA?oc=5","date":"2026-03-11","type":"pipeline","source":"Contract Pharma","summary":"Agilent Launches Advanced Therapeutics CDMO Solution for US and Canada - Contract Pharma","headline":"Agilent Launches Advanced Therapeutics CDMO Solution for US and Canada","sentiment":"neutral"},{"date":"2026-03-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE53Ulc0MVRkanRrTk40aHM3OVZvMGVnbjZsNlBIdldiTGhNSW50Q2Vkel9nbVlTWks5SWVvSUMxTVM5YTR5a0FuMDV5WEhQSnRUUG1pTTZYbmJUcWhaSS1yaFZMZG5kZmxBaU5oUkZn?oc=5","date":"2026-03-05","type":"deal","source":"Morningstar","summary":"The Best Healthcare Stocks to Buy - Morningstar","headline":"The Best Healthcare Stocks to Buy","sentiment":"neutral"},{"date":"2026-03-03","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNblN0Yk5Bb1R0X3M2RlE4dkJtOHROZkJ2NXNPR1NuejZmb1c0by1COEljOWZ5NW1GajdndERROWpobTJ3NzFuQlJLekFTeTFwZzNGNVQ4aEVjVVdOWjMwVmJ3TGRQZDFYLW4ybnBmTW5rQlI5SkJReE9mQm83eFd2RDRWWmJDMENzQTJqMDBzcw?oc=5","date":"2025-12-08","type":"pipeline","source":"Pharmaceutical Technology","summary":"Agilent and Monash University Malaysia to set up biodiscovery hub - Pharmaceutical Technology","headline":"Agilent and Monash University Malaysia to set up biodiscovery hub","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE1tczB1d2h1WFlWZS1tcEc1UTVqWWdYdHRMcm5VNU13ZUxTYUZCNzlDQVg5U2dsTmhCWjZIbmNTTTM1VVpDcFVELTJBakgyenJRazQ0STdVVUswQ3BOcVIzRkFoYw?oc=5","date":"2025-11-25","type":"earnings","source":"medwatch.com","summary":"Agilent Technologies disappoints with new earnings forecast - medwatch.com","headline":"Agilent Technologies disappoints with new earnings forecast","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-29","type":"pipeline","source":"ET Pharma","summary":"Agilent Technologies launches Biopharma Experience Centre in Hyderabad - ET Pharma","headline":"Agilent Technologies launches Biopharma Experience Centre in Hyderabad","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxPMjdWZ2lwQnZaclNOcGsySFp2cDQ5NFpGc19JX0stckNiU0p2YktSR2p2dU55bk1DXzBmeHIxdmxFOXBmek5IbjdPWlhOQ2w0cDdLSXh4NGhkV0lNc0RldERYRXVUXzI1TU1PSTR4d2FiN092MVU3YUtqcG5CODRyaWhUSHVGTnU4RVRWWXZUVU5FYjE1Rnc5bVNZMGJPYVRVLUVGNUJtLXk4bnpheW5TZ3lyeFdROWFyRU1OWHZtLWNPMHV5dFIyeDN6bHRjd0YwbElwOHl2WkdLMUpEZGo2U21lY3JoNVR1SnZNTTFn?oc=5","date":"2025-05-30","type":"pipeline","source":"BioPharma APAC","summary":"Agilent Launches InfinityLab Pro iQ Series to Elevate LC-MS Detection Across Pharma, Biotech, and Advanced Research - BioPharma APAC","headline":"Agilent Launches InfinityLab Pro iQ Series to Elevate LC-MS Detection Across Pharma, Biotech, and Advanced Research","sentiment":"neutral"}],"patents":[{"drugName":"IgM Enzyme-Linked Immunosorbent Assay (ELISA)","drugSlug":"igm-elisa","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":100000000},{"drugName":"Agilent's Mass Spectrometry Systems","drugSlug":"mass-spectrometry-systems","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":500000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Thermo Fisher Scientific","PerkinElmer","Danaher Corporation"],"therapeuticFocus":["Genomics","Diagnostics"],"financials":{"source":"sec_edgar","revenue":4472000000,"revenuePeriod":"2017-10-31","revenueHistory":[{"value":4472000000,"period":"2017-10-31"},{"value":4202000000,"period":"2016-10-31"},{"value":4202000000,"period":"2016-10-31"},{"value":4038000000,"period":"2015-10-31"},{"value":4038000000,"period":"2015-10-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":455000000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":1303000000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":12727000000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":116.61,"previousClose":113.88,"fiftyTwoWeekHigh":160.27,"fiftyTwoWeekLow":96.43,"fiftyTwoWeekRange":"96.43 - 160.27","fiftyDayAverage":121.47,"twoHundredDayAverage":129.76,"beta":1.3,"enterpriseValue":33974751232,"forwardPE":17.7,"priceToBook":4.77,"priceToSales":4.67,"enterpriseToRevenue":4.81,"enterpriseToEbitda":17.24,"pegRatio":1.21,"ebitda":1971000064,"ebitdaMargin":27.9,"freeCashflow":855875008,"operatingCashflow":1396000000,"totalDebt":3550000128,"debtToEquity":51.4,"currentRatio":2.07,"returnOnAssets":8.5,"returnOnEquity":19.9,"analystRating":"1.7 - Buy","recommendationKey":"buy","numberOfAnalysts":16,"targetMeanPrice":161.94,"targetHighPrice":185,"targetLowPrice":140,"dividendRate":1.02,"payoutRatio":0.22,"fiveYearAvgDividendYield":0.67,"exDividendDate":1774915200,"insiderHeldPercent":0.2,"institutionHeldPercent":93.6,"sharesOutstanding":282602317,"floatShares":281647121,"sharesShort":4778684,"shortRatio":1.76,"shortPercentOfFloat":1.7,"epsTrailing":4.53,"epsForward":6.57,"revenuePerShare":24.92,"bookValue":24.44,"officers":[{"age":53,"name":"Mr. Padraig  McDonnell","title":"CEO, President & Director"},{"age":59,"name":"Mr. Rodney  Gonsalves","title":"VP, Corporate Controller & Principal Accounting Officer"},{"age":57,"name":"Mr. Bret M. DiMarco","title":"Senior VP, Chief Legal Officer, & Secretary"},{"age":54,"name":"Ms. Angelica A. Riemann","title":"Senior VP & President of Agilent CrossLab Group"},{"age":52,"name":"Dr. Simon  May","title":"Senior VP and President of Life Sciences & Diagnostics Markets Group"},{"age":47,"name":"Mr. Adam S. Elinoff","title":"Senior VP, CFO & Principal Financial Officer"},{"age":null,"name":"Mr. August  Specht Ph.D.","title":"Senior VP & Chief Technology Officer"},{"age":null,"name":"Mr. Tejas Rajeev Savant","title":"Vice President of Investor Relations"}],"industry":"Diagnostics & Research","irWebsite":"http://www.investor.agilent.com/phoenix.zhtml?c=103274&p=irol-irhome","website":"https://www.agilent.com","phone":"800 227 9770"}}